|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.850 USD | +1.05% |
|
-4.94% | -23.90% |
| 05-11 | SCYNEXIS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-20 | SCYNEXIS, Inc. Announces Retirement of Director Steven C. Gilman | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCYNEXIS, INC. | Other Pharmaceuticals | +1.05% | -4.94% | -23.90% | -30.38% | -93.95% | 38.23M |  | | |
- Stock Market
- Stocks
- SCYX Stock
- Charts SCYNEXIS, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
